Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00534053 · ClinicalTrials.gov registry record · NA

Impact of a Mailed Educational Reminder on Fecal Occult Blood Testing (FOBT): A Randomized Controlled Trial

A NA study, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
775
Enrollment target

NCT00534053: Completed NA study, sponsored by University of California, San Diego.

NCT00534053 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 775 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (45% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00534053, a NA study, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
775 participants
Enrollment target

Study Summary

The purpose of our randomized controlled trial is to determine whether mailed educational reminders would increase fecal occult blood test (FOBT) card return rates and, therefore, improve patient compliance with colonrectal cancer (CRC) screening. We will conduct a randomized, controlled trial to evaluate the hypothesis that compliance to FOBT referrals is at least 10% greater among patients who receive mailed educational reminders on the importance of CRC screening. The study will be conducted in Veteran Affairs Medical Center and surrounding VA clinics in San Diego.

Interventions

  • OTHER Mailed Educational Reminder

Trial Details

FieldValue
Enrollment Target 775 participants
Start Date 2007-06
Est. Completion 2009-12
Phase NA
University of California, San Diego

775 total trials

What the finished NCT00534053 record still lists

NCT00534053 is an interventional study that assigns participants to a tested intervention. The registered 775 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (45% lower).

The record links to 0 conditions, and to 1 intervention - of which Mailed Educational Reminder is the first listed.

NCT00534053 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00534053 about?

NCT00534053 is a clinical study titled "Impact of a Mailed Educational Reminder on Fecal Occult Blood Testing (FOBT): A Randomized Controlled Trial". The purpose of our randomized controlled trial is to determine whether mailed educational reminders would increase fecal occult blood test (FOBT) card return rates and, therefore, improve patient compliance with colonrectal cancer (CRC) screening. We will conduct a randomized, controlled trial to e...

What is the current status of trial NCT00534053?

This trial is currently completed. It is a NA study. The enrollment target is 775 participants. The study started on 2007-06. Estimated completion is 2009-12.

What interventions are being tested in trial NCT00534053?

The interventions under investigation include: Mailed Educational Reminder (OTHER).

Who is sponsoring clinical trial NCT00534053?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00534053's enrollment target sits among peer trials

775 143rd of 2000 higher than 1,858 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03460769 · 775 participants

    Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)

  • NCT06145763 · 776 participants · NA

    A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial

  • NCT05642611 · 777 participants · Phase 3

    Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

  • NCT06841679 · 778 participants · Phase 2

    Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00534053, the US trial registry maintained by the National Library of Medicine. NCT00534053 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.